Qube Research & Technologies (QRT)
BMY.RT

Qube Research & Technologies (QRT)’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-100,099
Closed -$69K – 2637
2020
Q4 		$69K Sell
100,099
-50,000
-33% -$107K ﹤0.01% 1678
2020
Q3 		$9.05M Buy
150,099
+100,000
+200% +$286K 0.13% 195
2020
Q2 		$2.95M Hold
50,099
– – 0.04% 531
2020
Q1 		$2.79M Sell
50,099
-174,608
-78% -$575K 0.11% 167
2019
Q4 		$0 Buy
+224,707
New +$584K ﹤0.01% 1609

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BMY.RT Position: Q1 2021 in Review

Qube Research & Technologies (QRT) sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 100,099 shares — an estimated $69K sold.

Qube Research & Technologies (QRT) first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $9.05M in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Qube Research & Technologies (QRT) reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 100,099 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $69K.
  • Qube Research & Technologies (QRT) first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Bristol-Myers Squibb Company Contingent Value Rights position peaked at $9.05M in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2021, filed 14 May 2021.